JNJ vs VST: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Vistra Corp. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
VS
Vistra Corp. · Utilities
$140.58
+20.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
VST has more upside to fair value
(+20.9%).
VST trades at a lower forward P/E
(15.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
VST |
| Current Price |
$253.85 |
$140.58 |
| Fair Value Estimate |
$198.76 |
$170.00 |
| Upside to Fair Value |
-21.7%
|
+20.9%
|
| Market Cap |
$611.1B |
$47.4B |
| Forward P/E |
29.3x
|
15.4x
|
| EV / EBITDA |
19.2x
|
9.3x
|
| Price / Sales |
6.3x
|
2.9x
|
| Price / FCF |
34.3x
|
42.5x
|
| Revenue Growth YoY |
+9.9%
|
+20.0%
|
| Gross Margin |
69.1%
|
12.7%
|
| Operating Margin |
26.9%
|
2.1%
|
| Return on Equity |
26.3%
|
35.0%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
2.91%
|
2.4%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
Vistra is an integrated merchant power producer and retail electricity supplier with roughly 38,700 MW of generation across natural gas, nuclear, coal, solar and battery storage, plus a roughly 4.3 million customer retail book (TXU and affiliated brands) across 20 states. The 2024 Energy Harbor deal made it the second-largest nuclear operator in the US, and that nuclear and gas fleet is now centr…
Accumulation Zones
| Metric |
JNJ |
VST |
| Zone Low |
$149.07 |
$128.00 |
| Zone High |
$168.95 |
$145.00 |
| In Buy Zone? |
No
|
Yes
|